Legal Liability of Pediatricians for Medical Interventions Involving Anti-Seizure Intravenous Drug Administration Resulting in Severe Patient Compliations at Mohammad Hoesin Hospital Palembang

Authors

  • Kemas Muhammad Dahlan Universitas Muhammadiyah Palembang, Palembang, Indonesia
  • Mulyadi Tanzili Universitas Muhammadiyah Palembang, Palembang, Indonesia
  • Helwan Kasra Universitas Muhammadiyah Palembang, Palembang, Indonesia

DOI:

https://doi.org/10.38035/jlph.v7i1.3986

Keywords:

Legal Liability, Pediatrician, Medical Procedure, Administration of Anticonvulsant Infusion, Harm to a Patient

Abstract

The research questions are: What is the legal liability of a pediatrician regarding the administration of an intravenous anti-seizure medication that results in harm to the patient? and What factors influence the legal liability of a pediatrician regarding the administration of an intravenous anti-seizure medication that results in harm to the patient?. The findings indicate that: First, a pediatrician's legal liability for the administration of an anticonvulsant infusion that harms a patient at RSUP Dr. Mohammad Hoesin Palembang may encompass criminal, civil, and administrative aspects, provided that errors or negligence such as violations of professional standards, service protocols, standard operating procedures (SOPs), or prevailing laws are proven. In emergency situations, life-saving interventions that align with medical indications and professional standards do not incur legal liability, provided that any resulting harm constitutes an acceptable medical risk. Furthermore, the factors influencing a pediatrician's legal liability include the adequacy of legal frameworks and facilities; the need for improved understanding among law enforcement officials in distinguishing between inherent medical risks and medical negligence; and societal and cultural factors stemming from a limited understanding of the risks associated with medical procedures, excessively high expectations for recovery, and the common, yet often inaccurate, assumption that any complication is necessarily the result of a physician's error.

References

Angurana, SK, & Suthar, R. (2021). Efficacy and safety of levetiracetam vs. phenytoin as second line antiseizure medication for pediatric convulsive status epilepticus: A systematic review and meta-analysis of randomized controlled trials. Journal of Tropical Pediatrics, 67 (2), fmab014. https://doi.org/10.1093/tropej/fmab014

Besli, GE, Karatoprak, E.Y., & Yilmaz, S. (2020). Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children. Epilepsy & Behavior, 111, 107289. https://doi.org/10.1016/j.yebeh.2020.107289

Desyari, G., Syam, MH, & Makaginsar, C. (2023). Doctors' legal responsibility for medical malpractice after cardiopulmonary resuscitation: A case study in Central Jakarta, Decision Number 1145K/Pdt/2017. Indonesian Health Law Journal, 3 (2), 57–65.

Farkas, M.K., et al. (2023). Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open-label, phase 2/3 trial. Epilepsia Open, 8 (1), 146–153.

Giannaccini, C., et al. (2024). Determining the safety and tolerability of rapid administration of undiluted intravenous levetiracetam in pediatrics. Journal of Child Neurology, 39 (7–8). https://doi.org/10.1177/08830738241255992

Ginanjar, SS, & Syam, MH (2025). Doctors' legal responsibility for negligence in providing postpartum health services in hospitals that harm patients according to Law Number 17 of 2023 concerning Health. Bandung Conference Series: Law Studies, 5 (2), 1320–1327.

Gunawan, MA, Holijah, & Wardhana, AW (2021). Legal protection for doctors in providing circumcision [Master's thesis, Muhammadiyah University of Palembang]. http://repository.um-palembang.ac.id/id/eprint/21576/

Guwandi, J. (2021). Doctors, patients, and the law. Faculty of Medicine, University of Indonesia.

Guwandi, J. (2021). Medical error and medical law. Faculty of Medicine, University of Indonesia.

Hadjon, PM (2020). Legal protection for the Indonesian people. Civilization.

Hanafiah, MJ (2020). Medicine, ethics, and law. EGC Medical Books.

Hanafiah, MJ, & Amir, A. (2021). Medical ethics and health law. EGC Medical Books.

Indonesian Medical Association. (2022). Indonesian Code of Medical Ethics (KODEKI). IDI Executive Board.

Indonesian Medical Council. (2021). Guidelines for enforcing professional discipline in doctors. KKI.

Isfandyarie, A., & Fahrizal, A. (2020). Legal responsibilities and sanctions for doctors. Kencana.

Kartek, M., Kannan, A., Anand, V., & Sahoo, M.R. (2024). Intravenous levetiracetam versus intravenous phenytoin as second line treatment in pediatric convulsive status epilepticus—Open label randomized controlled trial. Journal of Family Medicine and Primary Care, 13 (8), 3368–3373. https://doi.org/10.4103/jfmpc.jfmpc_1747_23

Komalawati, V. (2021). The role of informed consent in therapeutic transactions. PT Citra Aditya Bakti.

Komalawati, V. (2022). Indonesian health law (6th edition). PT Citra Aditya Bakti.

Machmud, S. (2021). Law enforcement and legal protection for doctors suspected of medical malpractice. CV Mandar Maju.

Mahdi, M., Holijah, & Wardhana, AW (2021). Legal protection for health workers in performing medical procedures in health services based on Indonesian positive law [Master's thesis, Muhammadiyah University of Palembang]. http://repository.um-palembang.ac.id/id/eprint/16776/

Moleong, LJ (2023). Qualitative research methodology. Rineka Cipta.

Muhammad Bayumi, Ruben Achmad, & Mulyadi Tanzili. (2024). Legal analysis of malpractice cases in medical practice: Criminal law perspective and legal protection of the medical profession. Master of Law Study Program, Muhammadiyah University of Palembang.

Nasution, BJ (2020). Health law: Doctors' accountability. Rineka Cipta.

Nugraha, A., Wulandari, L., & Natsir, NI (2023). Criminal liability for medical negligence resulting in death from a positive legal perspective in Indonesia. Parhesia, 1 (2), 115–120.

Price, L., Garrity, L., & Stiehl, S. (2024). Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution. Pharmacotherapy, 44 (2), 141–148. https://doi.org/10.1002/phar.2898

Rahardjo, S. (2021). Law and society. Angkasa.

Sharawat, IK, et al. (2024). Efficacy and safety of phenytoin and levetiracetam for acute symptomatic seizures in children with acute encephalitis syndrome: An open label, randomized controlled trial. Seizure: European Journal of Epilepsy, 118, 110–116.

Singh, R., Troelstrup, D., & Dahl, N. (2024). Safety and tolerability of intravenous undiluted levetiracetam in pediatrics: A retrospective cohort study. Epilepsia, 65 (12), e204–e208. https://doi.org/10.1111/epi.18157

Soewono, H. (2020). Protection of patient rights in therapeutic transactions. Rajawali Press.

Susila, ME (2026). Socio-legal implications of criminal charges against doctors related to alleged medical malpractice. Scientific Journal of the World of Law, 1 (1).

Triana, Y., Setianari, I., Mahendra, & Akbar, F. (2023). Regulations on hospital liability for doctors' actions that commit medical negligence. Journal of Education and Counseling (JPDK), 5 (2), 2186–2191.

Downloads

Published

2026-11-17

How to Cite

Dahlan, K. M., Tanzili, M., & Kasra, H. (2026). Legal Liability of Pediatricians for Medical Interventions Involving Anti-Seizure Intravenous Drug Administration Resulting in Severe Patient Compliations at Mohammad Hoesin Hospital Palembang. Journal of Law, Politic and Humanities, 7(1), 137–149. https://doi.org/10.38035/jlph.v7i1.3986